HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Is Campylobacter lipopolysaccharide bearing a GD3 epitope essential for the pathogenesis of Guillain-Barré syndrome?

Abstract
The hypothesis has been proposed that the GD3 ganglioside-like lipopolysaccharide (LPS) is essential for and functions in the development of Guillain-Barré syndrome (GBS) and Miller Fisher syndrome (MFS) subsequent to Campylobacter jejuni enteritis. Our study showed that patients with GBS or MFS who had previously suffered diarrhea had anti-GD3 antibodies less often than those who had not had diarrhea. Sera from patients who showed GBS or MFS with the serologic evidence of prior C. jejuni infection had anti-GD3 antibodies less frequently than sera from those without evidence of infection. Statistical analysis showed that anti-GD3 antibodies were less frequent in patients with GBS or MFS from whom C. jejuni had been isolated than were other antiganglioside antibodies, such as anti-GM1 antibodies. These results could not support the above hypothesis.
AuthorsN Yuki, M Koga, K Hirata
JournalActa neurologica Scandinavica (Acta Neurol Scand) Vol. 102 Issue 2 Pg. 132-4 (Aug 2000) ISSN: 0001-6314 [Print] Denmark
PMID10949532 (Publication Type: Comparative Study, Journal Article, Research Support, Non-U.S. Gov't)
Chemical References
  • Antibodies, Bacterial
  • Epitopes
  • Gangliosides
  • Immunoglobulin G
  • Lipopolysaccharides
  • ganglioside, GD3
Topics
  • Acute Disease
  • Antibodies, Bacterial (blood)
  • Campylobacter Infections (complications, immunology, microbiology)
  • Campylobacter jejuni (immunology, isolation & purification)
  • Case-Control Studies
  • Diarrhea (etiology, immunology)
  • Epitopes
  • Female
  • Gangliosides (immunology)
  • Gastroenteritis (complications, immunology, microbiology)
  • Guillain-Barre Syndrome (etiology, immunology, microbiology)
  • Humans
  • Immunoglobulin G
  • Lipopolysaccharides (immunology)
  • Male
  • Miller Fisher Syndrome (immunology, microbiology)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: